TULSA, Okla.--(BUSINESS WIRE)--HireRight, a leading provider of global employment background checks, drug testing, education verification, and electronic Form I-9 and E-Verify solutions, has expanded its COVID-19 Screening Solution in the U.S. through its Drug & Health Screening services. HireRight now offers COVID-19 viral marker (molecular via RT-PCR) assurance testing, as well as new referral options through Preworkscreen and CIC Health. These additional capabilities build on our previously announced ad hoc COVID-19 solution for symptomatic or exposed individuals to help employers screen large workforce populations to help prevent the spread of contagion.
As a leader in workplace risk mitigation, HireRight continues to be committed to helping our clients navigate the impact of the COVID-19 pandemic on their workforces by providing tools to address changes in their screening programs. Our COVID-19 screening solutions include:
- Ad hoc testing* through a COVID-19 viral marker test option that has been authorized by the FDA under Emergency Use Authorization (EUA). Employers can elect to order a COVID-19 viral marker test through the HireRight platform. The test detects the presence of coronavirus in the saliva of the test taker. Unlike blood draws or nasal swabs, the saliva sample is easily self-collected and is not technique dependent.
- Assurance testing* offers the same COVID-19 viral marker test that has been authorized by the FDA under Emergency Use Authorization (EUA), offered at periodic intervals for the entire workforce, usually at least once per week. This widespread testing of healthy people allows employers to return to full operations by helping identify cases of COVID-19 early – especially among employees who are either pre-symptomatic or asymptomatic without outward signs of infection – versus testing programs that focus on the testing of individuals who are symptomatic or who have suspected exposure to COVID-19.
- A COVID-19 Self-Assessment Tool through Preworkscreen to offer a simple and efficient way to conduct employee COVID-19 symptom questionnaires that aligns with CDC/State guidelines. Each day before work, employees complete the assessment on their mobile device of choice. Results are compiled in real-time and immediately available, so you can quickly track and monitor the overall health status of your workforce.
Additionally, in order to make cost effective, fast turn-around assurance testing available to larger enterprises, we are partnering with CIC Health, a leader in creating COVID-19 testing programs. Along with a full-service, low-cost testing solution from a nationwide network of laboratories, CIC Health can manage needed collectors and medical oversight of testing results.
HireRight has provided customers with guidance and assistance concerning various challenges arising as a result of the COVID-19 crisis. With the launch of these additional screening options, HireRight furthers our partnership for our clients by offering a range of COVID-19 viral marker test options that have been authorized by the FDA under Emergency Use Authorization (EUA).
“We continue to be committed to helping our clients move forward from the COVID-19 crisis and cultivate a safe workspace for their employees and customers,” said Dr. Todd Simo, Chief Medical Officer at HireRight. “The addition of COVID-19 assurance testing and referrals through Preworkscreen and CIC Health offers even more tools to help our clients return to as normal work operations as possible.”
More information on HireRight’s COVID-19 Screening services can be found at: https://www.hireright.com/services/drug-health-screening/COVID-19-Screening
HireRight helps employers hire the right candidates by delivering global employment background checks, drug testing, education verification, E-Verify solutions, and other workforce solutions. Employers can tailor HireRight’s extensive screening solutions to their unique needs, giving them peace of mind about their hiring and vetting processes. HireRight’s platform integrates with existing HR platforms and applicant tracking systems, giving organizations and candidates the best possible experience.
HireRight has U.S. offices in Irvine, Calif., Tulsa, Okla., Nashville, Tenn., Chapin, S.C., and Dallas, Texas, and international offices in Australia, Canada, Estonia, Hong Kong, India, Japan, Mexico, the Philippines, Poland, Singapore, the UAE, and the UK. Learn more at www.HireRight.com.
About CIC Health
CIC Health provides COVID-19 assurance testing services to organizations and individuals. We simplify testing by integrating CLIA-certified laboratories, physician oversight, result reporting, and billing software. Whether a one-time test or routine testing for a business, school, care facility, or consumers, our services are accessible, fast, and easy. https://www.cic-health.com/.
Preworkscreen's expert team is dedicated to developing state-of-the-art solutions that solve some of today’s most critical IT challenges. We specialize in delivering groundbreaking technologies in the areas of Cybersecurity, Deep Learning, Blockchain, Power Grid, and Communications. Currently, we are wielding our passion for innovation to provide advanced COVID-19 screening solutions to help businesses and organizations around the world keep their workplace safe. To find out more, please visit www.preworkscreen.com.
About Clinical Reference Laboratory
Clinical Reference Laboratory is one of the largest privately held clinical testing laboratories in the U.S., performing hundreds of thousands of tests every day for clients large and small. Our staff of more than 700 associates works around-the-clock to process and report results seven days a week for many of the largest retail, transportation, pharmaceutical, healthcare and financial service organizations in the world. From high-complexity molecular diagnostic COVID-19 testing, to our toxicology and general lab testing, our partners are as diverse as the testing we perform. Visit us at: https://www.crlcorp.com or call 833-567-8376 for more information.
*Additional Notes: This test has not been FDA cleared or approved. This test has been authorized by FDA under an Emergency Use Authorization for use by Clinical Reference Laboratory, Inc. located in Lenexa, Kansas. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.